Compare BUD & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BUD | SYK |
|---|---|---|
| Founded | 1366 | 1941 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.6B | 141.2B |
| IPO Year | N/A | N/A |
| Metric | BUD | SYK |
|---|---|---|
| Price | $61.05 | $363.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $71.50 | ★ $435.33 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.59% | 0.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.12 | ★ 7.61 |
| Revenue | ★ $58,605,000,000.00 | $24,381,000,000.00 |
| Revenue This Year | $0.69 | $11.94 |
| Revenue Next Year | $5.47 | $8.57 |
| P/E Ratio | ★ $19.55 | $47.87 |
| Revenue Growth | N/A | ★ 10.95 |
| 52 Week Low | $45.94 | $329.16 |
| 52 Week High | $72.13 | $406.19 |
| Indicator | BUD | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 43.72 | 46.18 |
| Support Level | $61.32 | $364.49 |
| Resistance Level | $62.92 | $374.10 |
| Average True Range (ATR) | 0.82 | 6.53 |
| MACD | -0.19 | 0.32 |
| Stochastic Oscillator | 11.79 | 34.01 |
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.